# OnCo record paper-nct04538664-n-engl-j-med-2023 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-nct04538664-n-engl-j-med-2023/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-nct04538664-n-engl-j-med-2023" ;
  schema:name "Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions"@en ;
  schema:description "Published report from the PAPILLON trial registered as NCT04538664, in New England Journal of Medicine (2023), chosen as the most cited paper whose own text cites the registry id."@en ;
  schema:url <https://onco.cc/key-papers/paper-nct04538664-n-engl-j-med-2023/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/nejmoa2306441>, <https://pubmed.ncbi.nlm.nih.gov/37870976/>, <https://europepmc.org/article/MED/37870976>, <https://clinicaltrials.gov/study/NCT04538664> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1056/nejmoa2306441> ;
  schema:datePublished "2023"^^xsd:gYear ;
  schema:author "Zhou C, Tang KJ, Cho BC, et al." ;
  onco:trials <https://onco.cc/trials/nct04538664/> ;
  onco:journals <https://onco.cc/journals/nejm/> .